• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

择期和半择期腹主动脉瘤开放修复手术患者头孢唑林的血浆和组织药代动力学。

Plasma and tissue pharmacokinetics of cefazolin in patients undergoing elective and semielective abdominal aortic aneurysm open repair surgery.

机构信息

Burns Trauma and Critical Care Research Centre, School of Medicine, The University of Queensland, Brisbane, Queensland, Australia.

出版信息

Antimicrob Agents Chemother. 2011 Nov;55(11):5238-42. doi: 10.1128/AAC.05033-11. Epub 2011 Aug 22.

DOI:10.1128/AAC.05033-11
PMID:21859939
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3195052/
Abstract

Surgical site infections are common, so effective antibiotic concentrations at the sites of infection, i.e., in the interstitial fluid (ISF), are required. The aim of this study was to evaluate contemporary perioperative prophylactic dosing of cefazolin by determining plasma and subcutaneous ISF concentrations in patients undergoing elective/semielective abdominal aortic aneurysm (AAA) open repair surgery. This was a prospective pharmacokinetic study in a tertiary referral hospital. Cefazolin (2 g) was administered as a 3-min slow bolus 30 min prior to incision in 12 enrolled patients undergoing elective/semielective AAA open repair surgery. Serial blood, urine, and ISF (via microdialysis) samples were collected and analyzed using a validated liquid chromatography-tandem mass spectrometry (LC-MS/MS) method. Cardiac output was determined using pulse waveform contours with Vigileo. The recruited patients had a median (interquartile range) age of 70 (66 to 76) years and weight of 88 (81 to 95) kg. The median (interquartile range) terminal volume of distribution was 0.14 (0.11 to 0.15) liter/kg, total clearance was 0.05 (0.03 to 0.06) liter/h, and minimum observed unbound concentration was 5.7 (5.4 to 8.1) mg/liter. The penetration of unbound drug from plasma to ISF was 85% (78% to 106%). We found correlations present, albeit weak, between cefazolin clearance and cardiac output (r(2) = 0.11) and urinary creatinine clearance (r(2) = 0.12). In conclusion, we found that a single 2-g dose of cefazolin administered 30 min before incision provides plasma and ISF concentrations in excess of the likely MICs for susceptible pathogens in patients undergoing AAA open repair surgery.

摘要

手术部位感染很常见,因此需要在感染部位(即间质液 [ISF])达到有效的抗生素浓度。本研究旨在通过评估接受择期/半择期腹主动脉瘤 (AAA) 开放修复手术患者的头孢唑林围手术期预防性给药剂量,来确定其当前的使用剂量。这是在一家三级转诊医院进行的前瞻性药代动力学研究。在 12 名接受择期/半择期 AAA 开放修复手术的患者中,在切开前 30 分钟,给予头孢唑林(2 g)静脉缓慢推注,推注时间为 3 分钟。采集并使用经过验证的液相色谱-串联质谱法(LC-MS/MS)分析了一系列血、尿和 ISF(通过微透析)样本。使用脉搏波形轮廓法(Vigileo)确定心输出量。招募的患者的中位(四分位间距)年龄为 70(66 至 76)岁,体重为 88(81 至 95)kg。中位(四分位间距)末端分布体积为 0.14(0.11 至 0.15)升/千克,总清除率为 0.05(0.03 至 0.06)升/小时,最低观察到的未结合浓度为 5.7(5.4 至 8.1)mg/升。未结合药物从血浆到 ISF 的穿透率为 85%(78% 至 106%)。我们发现,头孢唑林清除率与心输出量(r(2) = 0.11)和尿肌酐清除率(r(2) = 0.12)之间存在相关性,尽管相关性较弱。总之,我们发现,接受 AAA 开放修复手术的患者在切开前 30 分钟给予单次 2 g 剂量的头孢唑林,可提供超过易感病原体可能 MIC 的血浆和 ISF 浓度。

相似文献

1
Plasma and tissue pharmacokinetics of cefazolin in patients undergoing elective and semielective abdominal aortic aneurysm open repair surgery.择期和半择期腹主动脉瘤开放修复手术患者头孢唑林的血浆和组织药代动力学。
Antimicrob Agents Chemother. 2011 Nov;55(11):5238-42. doi: 10.1128/AAC.05033-11. Epub 2011 Aug 22.
2
Prophylactic Cefazolin Dosing in Women With Body Mass Index >35 kg·m-2 Undergoing Cesarean Delivery: A Pharmacokinetic Study of Plasma and Interstitial Fluid.体质量指数>35kg·m-2 的剖宫产产妇中头孢唑林的预防用药剂量:血浆和间质液的药代动力学研究。
Anesth Analg. 2020 Jul;131(1):199-207. doi: 10.1213/ANE.0000000000004766.
3
The pharmacokinetics of cefazolin in patients undergoing elective & semi-elective abdominal aortic aneurysm open repair surgery.头孢唑林在择期和半择期腹主动脉瘤开放修复手术患者中的药代动力学。
BMC Anesthesiol. 2011 Feb 22;11:5. doi: 10.1186/1471-2253-11-5.
4
Reduced subcutaneous tissue distribution of cefazolin in morbidly obese versus non-obese patients determined using clinical microdialysis.使用临床微透析法测定,与非肥胖患者相比,头孢唑林在病态肥胖患者皮下组织中的分布减少。
J Antimicrob Chemother. 2014 Mar;69(3):715-23. doi: 10.1093/jac/dkt444. Epub 2013 Nov 8.
5
In vivo microdialysis to measure antibiotic penetration into soft tissue during cardiac surgery.在心脏手术期间,采用体内微透析法测量抗生素向软组织的渗透情况。
Ann Thorac Surg. 2007 Nov;84(5):1605-10. doi: 10.1016/j.athoracsur.2007.06.052.
6
Plasma and Interstitial Fluid Pharmacokinetics of Prophylactic Cefazolin in Elective Bariatric Surgery Patients.择期减肥手术患者中头孢唑林预防用药的血浆和间质液药代动力学。
Antimicrob Agents Chemother. 2022 Jul 19;66(7):e0041922. doi: 10.1128/aac.00419-22. Epub 2022 Jun 28.
7
Skeletal muscle and plasma concentrations of cefazolin during cardiac surgery in infants.婴儿心脏手术期间头孢唑林在骨骼肌和血浆中的浓度。
J Thorac Cardiovasc Surg. 2014 Dec;148(6):2634-41. doi: 10.1016/j.jtcvs.2014.06.064. Epub 2014 Jul 22.
8
Comparative total and unbound pharmacokinetics of cefazolin administered by bolus versus continuous infusion in patients undergoing major surgery: a randomized controlled trial.头孢唑林经推注与连续输注给药在重大手术患者中的比较总代动力学和非结合型药代动力学:一项随机对照试验。
Br J Anaesth. 2017 Jun 1;118(6):876-882. doi: 10.1093/bja/aex026.
9
A pilot and feasibility study of the plasma and tissue pharmacokinetics of cefazolin in an immature porcine model of pediatric cardiac surgery.头孢唑林在未成熟猪小儿心脏手术模型中的血浆和组织药代动力学的初步和可行性研究。
Paediatr Anaesth. 2015 Nov;25(11):1111-9. doi: 10.1111/pan.12756. Epub 2015 Sep 15.
10
Pharmacokinetic characteristics and microbiologic appropriateness of cefazolin for perioperative antibiotic prophylaxis in elective cardiac surgery.头孢唑林用于择期心脏手术围手术期抗生素预防的药代动力学特征和微生物学适宜性。
J Thorac Cardiovasc Surg. 2016 Aug;152(2):603-10. doi: 10.1016/j.jtcvs.2016.04.024. Epub 2016 Apr 11.

引用本文的文献

1
The effect of intraoperative excessive bleeding on the pharmacokinetics of ampicillin and sulbactam in recipients of living donor liver transplantation in Japan.术中大量出血对日本活体肝移植受者氨苄西林和舒巴坦药代动力学的影响。
JAC Antimicrob Resist. 2025 Aug 26;7(4):dlaf149. doi: 10.1093/jacamr/dlaf149. eCollection 2025 Aug.
2
Systemic antibiotic prophylaxis in arthroplasty - a narrative review of how many doses are optimal.关节置换术中的全身性抗生素预防——关于最佳剂量的叙述性综述
EFORT Open Rev. 2024 Dec 2;9(12):1106-1119. doi: 10.1530/EOR-24-0022.
3
Interaction of Cephalosporins with Human Serum Albumin: A Structural Study.头孢菌素与人血清白蛋白的相互作用:结构研究。
J Med Chem. 2024 Aug 22;67(16):14175-14183. doi: 10.1021/acs.jmedchem.4c00983. Epub 2024 Jul 31.
4
Effective Antimicrobial Prophylaxis in Surgery: The Relevance and Role of Pharmacokinetics-Pharmacodynamics.手术中的有效抗菌预防:药代动力学-药效学的相关性及作用
Antibiotics (Basel). 2023 Dec 14;12(12):1738. doi: 10.3390/antibiotics12121738.
5
Peri-operative pharmacokinetics of cefazolin prophylaxis during valve replacement surgery.头孢唑林预防瓣膜置换手术围手术期药代动力学。
PLoS One. 2023 Sep 20;18(9):e0291425. doi: 10.1371/journal.pone.0291425. eCollection 2023.
6
Morphomics-informed population pharmacokinetic and physiologically-based pharmacokinetic modeling to optimize cefazolin surgical prophylaxis.形态计量学指导的群体药代动力学和基于生理的药代动力学模型优化头孢唑林手术预防用药。
Pharmacotherapy. 2024 Jan;44(1):77-86. doi: 10.1002/phar.2878. Epub 2023 Sep 29.
7
Tissue Penetration of Antimicrobials in Intensive Care Unit Patients: A Systematic Review-Part I.重症监护病房患者抗菌药物的组织穿透性:系统评价 - 第一部分
Antibiotics (Basel). 2022 Aug 29;11(9):1164. doi: 10.3390/antibiotics11091164.
8
An Overview of the Protein Binding of Cephalosporins in Human Body Fluids: A Systematic Review.头孢菌素在人体体液中的蛋白结合概述:一项系统综述
Front Pharmacol. 2022 Jun 28;13:900551. doi: 10.3389/fphar.2022.900551. eCollection 2022.
9
Plasma and Interstitial Fluid Pharmacokinetics of Prophylactic Cefazolin in Elective Bariatric Surgery Patients.择期减肥手术患者中头孢唑林预防用药的血浆和间质液药代动力学。
Antimicrob Agents Chemother. 2022 Jul 19;66(7):e0041922. doi: 10.1128/aac.00419-22. Epub 2022 Jun 28.
10
Biomarkers Predicting Tissue Pharmacokinetics of Antimicrobials in Sepsis: A Review.生物标志物预测脓毒症中抗菌药物的组织药代动力学:综述。
Clin Pharmacokinet. 2022 May;61(5):593-617. doi: 10.1007/s40262-021-01102-1. Epub 2022 Feb 25.

本文引用的文献

1
Pharmacokinetics and protein binding of cefazolin in morbidly obese patients.头孢唑林在病态肥胖患者中的药代动力学和蛋白结合。
Eur J Clin Pharmacol. 2011 Oct;67(10):985-92. doi: 10.1007/s00228-011-1048-x. Epub 2011 Apr 16.
2
The pharmacokinetics of cefazolin in patients undergoing elective & semi-elective abdominal aortic aneurysm open repair surgery.头孢唑林在择期和半择期腹主动脉瘤开放修复手术患者中的药代动力学。
BMC Anesthesiol. 2011 Feb 22;11:5. doi: 10.1186/1471-2253-11-5.
3
Augmented creatinine clearance in traumatic brain injury.创伤性脑损伤时的肌酐清除率增加。
Anesth Analg. 2010 Dec;111(6):1505-10. doi: 10.1213/ANE.0b013e3181f7107d. Epub 2010 Nov 3.
4
Augmented renal clearance: implications for antibacterial dosing in the critically ill.增强的肾功能清除:对危重症患者抗菌药物剂量的影响。
Clin Pharmacokinet. 2010;49(1):1-16. doi: 10.2165/11318140-000000000-00000.
5
Soft tissue penetration of cefuroxime determined by clinical microdialysis in morbidly obese patients undergoing abdominal surgery.通过临床微透析法测定接受腹部手术的病态肥胖患者中头孢呋辛的软组织渗透情况。
Int J Antimicrob Agents. 2009 Sep;34(3):231-5. doi: 10.1016/j.ijantimicag.2009.03.019. Epub 2009 May 2.
6
Pharmacokinetic issues for antibiotics in the critically ill patient.危重症患者使用抗生素的药代动力学问题。
Crit Care Med. 2009 Mar;37(3):840-51; quiz 859. doi: 10.1097/CCM.0b013e3181961bff.
7
Tissue concentrations: do we ever learn?组织浓度:我们究竟学到了什么?
J Antimicrob Chemother. 2008 Feb;61(2):235-7. doi: 10.1093/jac/dkm476. Epub 2007 Dec 6.
8
Quantification of lean bodyweight.瘦体重的量化
Clin Pharmacokinet. 2005;44(10):1051-65. doi: 10.2165/00003088-200544100-00004.
9
Detection of abdominal aortic aneurysm in patients with peripheral artery disease.外周动脉疾病患者腹主动脉瘤的检测。
Eur J Vasc Endovasc Surg. 2005 Nov;30(5):504-8. doi: 10.1016/j.ejvs.2005.05.011. Epub 2005 Jun 15.
10
National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004.国家医院感染监测(NNIS)系统报告,1992年1月至2004年6月数据总结,2004年10月发布。
Am J Infect Control. 2004 Dec;32(8):470-85. doi: 10.1016/S0196655304005425.